What is the clinical evidence from this study?

Study design: Cohort. Population: Obesity and its relation to metabolic diseases and cardiovascular health (n=240000). Intervention: Metabolically healthy obesity (MHO). Primary outcome: All-cause and cardiovascular disease mortality (HR 1.50, 95% CI 1.30-1.70, p=<0.001).

What does this research mean for the field?

Adipose tissue fibrosis is a critical pathological mechanism that influences weight loss responsiveness and long-term prognosis in obese patients. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This review explores the role of adipose tissue fibrosis in obesity and its implications for treatment efficacy and metabolic health.

January 9, 2026The Korean Journal of Internal MedicineOpen Access

Individuals with metabolic syndrome have higher risks for all-cause and cardiovascular mortality compared to those without metabolic syndrome.

Q: What are the key findings of this study?

Q: What does this research mean for the field?

Adipose tissue fibrosis is a critical pathological mechanism that influences weight loss responsiveness and long-term prognosis in obese patients. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

Q: What question did this study set out to answer?

This review explores the role of adipose tissue fibrosis in obesity and its implications for treatment efficacy and metabolic health.

View Full Paper

Ask AI

Bookmark

Key result

Individuals with metabolic syndrome have higher risks for all-cause and cardiovascular mortality compared to those without metabolic syndrome.

Authors

MSMihye Seo KSKyoil Suh HPHyeong Kyu Park

Discussion

Member takes

Overview

This review highlights adipose tissue fibrosis' role in obesity prognosis and therapy effectiveness, suggesting a need for targeted strategies.

Key Points

This review explores the role of adipose tissue fibrosis in obesity and its implications for treatment efficacy and metabolic health.
Comprehensive literature review of recent research findings
Analysis of longitudinal studies spanning over 24 years
Examination of anti-diabetic therapies and their effects on adipose tissue
Incorporation of advancements in spatial transcriptomics and single-cell omics
Weight loss correlates with reduced metabolic complications in obese individuals
Adipose tissue dysfunction and fibrosis contribute to weight regain
Anti-diabetic therapies improve tissue remodeling and reduce fibrosis
Adipose tissue fibrosis is identified as a potential predictive and therapeutic target for obesity management

Study Design

Type

Cohort (n=240,000)

Multicenter

PICO

Population

Obesity and its relation to metabolic diseases and cardiovascular health (n=240,000)

Intervention / Comparator

Metabolically healthy obesity (MHO)

Primary Outcome

All-cause and cardiovascular disease mortality — HR 1.50 (1.30-1.70), p=<0.001

Main Result

Effect estimate: HR 1.50 (95% CI 1.30-1.70)

p-value: p=<0.001

Cite This Study

Seo et al. (2025) conducted a cohort in Obesity and its relation to metabolic diseases and cardiovascular health (n=240,000). Metabolically healthy obesity (MHO) was evaluated on All-cause and cardiovascular disease mortality (HR 1.50, 95% CI 1.30-1.70, p=<0.001). Individuals with metabolic syndrome have higher risks for all-cause and cardiovascular mortality compared to those without metabolic syndrome.

synapsesocial.com/papers/69612fe730ef6c21f6853f82 https://doi.org/10.3904/kjim.2025.363

View Full Paper

Ask AI

Bookmark

January 9, 2026The Korean Journal of Internal MedicineOpen Access

Individuals with metabolic syndrome have higher risks for all-cause and cardiovascular mortality compared to those without metabolic syndrome.

View Full Paper

Ask AI

Bookmark

Key result

Individuals with metabolic syndrome have higher risks for all-cause and cardiovascular mortality compared to those without metabolic syndrome.

Authors

MSMihye Seo KSKyoil Suh HPHyeong Kyu Park

Discussion

Member takes

Overview

This review highlights adipose tissue fibrosis' role in obesity prognosis and therapy effectiveness, suggesting a need for targeted strategies.

Key Points

This review explores the role of adipose tissue fibrosis in obesity and its implications for treatment efficacy and metabolic health.
Comprehensive literature review of recent research findings
Analysis of longitudinal studies spanning over 24 years
Examination of anti-diabetic therapies and their effects on adipose tissue
Incorporation of advancements in spatial transcriptomics and single-cell omics
Weight loss correlates with reduced metabolic complications in obese individuals
Adipose tissue dysfunction and fibrosis contribute to weight regain
Anti-diabetic therapies improve tissue remodeling and reduce fibrosis
Adipose tissue fibrosis is identified as a potential predictive and therapeutic target for obesity management

Study Design

Type

Cohort (n=240,000)

Multicenter

PICO

Population

Obesity and its relation to metabolic diseases and cardiovascular health (n=240,000)

Intervention / Comparator

Metabolically healthy obesity (MHO)

Primary Outcome

All-cause and cardiovascular disease mortality — HR 1.50 (1.30-1.70), p=<0.001

Main Result

Effect estimate: HR 1.50 (95% CI 1.30-1.70)

p-value: p=<0.001

Cite This Study

synapsesocial.com/papers/69612fe730ef6c21f6853f82 https://doi.org/10.3904/kjim.2025.363

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark